|
We invite your feedback
as we continue to improve and expand the value of our Web site. |
||
H.E.R.O.™ Solutions
Helping to Improve Healthcare Efficiencies, Results, & Outcomes
BD Diagnostics is recognized as the worldwide leader in providing the most relevant, rapid, high quality solutions for clinical microbiology and infection control. From specimen collection through final report, improve outcomes, everywhere, every time. *Healthcare-associated infections |
|
H.E.R.O. Solutions for HAI Prevention and Management Preventing the spread of drug-resistant bacteria is essential to any infection prevention and control program. Active surveillance testing for MRSA and VRE colonization is a proven, essential intervention strategy for preventing multidrug-resistant organism-associated HAIs, and is recommended by CDC, SHEA, APIC and IHI. 1-4 | |
|
H.E.R.O. Solutions for Methicillin-Resistant Staphylococcus aureus Detection
BBL™ CHROMagar™ MRSA
BD GeneOhm™ MRSA Assay
ACCURACY that meets and exceeds guidelines LAB RESULTS WITHIN 2 HOURS versus 2-3 days EARLIER INTERVENTION:
H.E.R.O. Solutions for Blood CulturingBD BACTEC™ FX WORKFLOW EFFICIENCIES: ACTIONABLE RESULTS:
H.E.R.O. Solutions for Identification of MRSA/SA from Positive Blood Culture 2 HOUR laboratory results VERSUS 2-3 DAYS SIMPLE, USER-FRIENDLY WORKFLOW AIDS IN THE DIFFERENTIATION OF MRSA/SA and potential contaminants such as Coagulase Negative Staphylococci
H.E.R.O. Solutions for Identification and Susceptibility RAPID ID/AST RESULTS AUTOMATED DETECTION of emerging resistance INTERFACES to the BD EpiCenter™ ONLY AUTOMATED nephelometry system for ID/AST STANDARDIZED isolate inoculum REDUCES technologist's "HANDS-ON TIME"
H.E.R.O. Solutions for Lean Microbiology Enhance VISUAL DIFFERENTIATION of colonies with highly specific chromogenic reactions DECREASE material and labor costs
H.E.R.O. Solutions for Data Management SEAMLESSLY CONNECTS to all microbiology systems MULTIPLE EXPERT SYSTEMS improve result accuracy and consistency |
|
1. www.cdc.gov/ncidod/dhqp/dhqp/pd/ar/mdroguideline2006.pdf
2. www.shea-online.org/assets/files/position_papers/SHEA_MRSA_VRE.pdf
3. www.ihi.org
4. Huang, S.S., Yokoe, D.S. Hinrichsen, V.L., et al. Impact of routine intensive care unit surveillance cultures and resultant barrier precautions on hospital-wide methicillin-resistant Staphylococcus aureus bacteremia. CID. 2006:43:971-8.
5. www.apic.org
CHROMagar is a trademark of Dr. A. Rambach.

HAI* Prevention and Management




